<DOC>
	<DOCNO>NCT00002322</DOCNO>
	<brief_summary>To determine tolerance antiviral response two different dos atevirdine mesylate ( U-87201E ) symptomatic HIV-positive patient CD4 count 50-350 cells/mm3 , also take zidovudine ( AZT ) .</brief_summary>
	<brief_title>A Study Different Doses Atevirdine Mesylate Plus Zidovudine HIV-Positive Patients</brief_title>
	<detailed_description>Patients randomize 1 3 treatment group : U-87201E 1 2 dos placebo administer every 8 hour . Patients must take AZT least 3 month prior randomization .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Atevirdine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Primary secondary prophylaxis opportunistic infection . Patients must : HIV infection . Symptoms ( currently prior enrollment ) include Category B C CDC classification , although THE FOLLOWING CURRENT ACUTE MEDICAL CONDITIONS ARE NOT ALLOWED : Cryptococcosis Pneumocystis carinii pneumonia Herpes zoster Histoplasmosis CMV Hepatic renal disease Lymphoma . CD4 count 50 350 cells/mm3 within 14 day prior study entry . Ongoing therapy AZT 500 600 mg total daily dose least 3 month prior study entry . Consent parent , guardian , person power attorney le 18 year age . Exclusion Criteria Coexisting Condition : Patients follow condition exclude : Intolerance AZT . Current diagnosis malignancy systemic therapy require study . Concurrent Medication : Excluded : Any investigational drug . Prior Medication : Excluded : Cytotoxic chemotherapy within 1 month prior study entry . Prior U87201E nonnucleoside antiretroviral medication , include limited nevirapine , TIBO R82150 TIBO R82913 , L697639 L696229 , U90152S , protease inhibitor . Antiretroviral agent AZT within 3 month prior study entry . Required : AZT least 3 month prior study entry . Present use excessive alcohol illicit drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1996</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>